Background: Although penile cancer is a rare malignancy in developed nations
Introduction
Penile cancer is rare in the United States, with an estimated 2,030 new cases in the United States and 340 related deaths estimated to occur this year. 1 However, its incidence is higher in some countries of Asia, Africa, and South America, where it represents 10% of all malignancies diagnosed among men. 2 Patients with penile cancer appear to have a distinct epidemiological profile consisting of lower income and education levels, poor hygiene, a history of sexually transmitted infections, phimosis, and multiple sexual partners. 3 Risk factors for penile cancer include lack of circumcision, presence of phimosis or paraphimosis, poor hygiene, human papillomavirus (HPV) infection, presence of genital warts, chronic inflammatory conditions of the foreskin, glans penis, or penile shaft (eg, balanitis xerotica obliterans, lichen sclerosis), presence of smegma (a whitish substance that accumulates underneath the foreskin), tobacco abuse, or history of psoriasis treatment with ultraviolet light. 4, 5 Tumor grade and stage, basaloid or sarcomatoid histological features, and the presence and extent of lymph-node (LN) involvement in the groin or pelvis have all been identified as important prognostic factors for penile cancer in determining long-term, cancer-related survival outcomes. 6 In addition to disease-specific characteristics, significant demographical, racial/ethnic, social, and economic disparities exist with regard to both the incidence and survival rates of penile cancer. 7 This is especially important considering the diverse patient population in which this disease presents. 2 These findings also highlight the importance of considering these differences when developing health care policies to help improve access to standard medical care and reduce the treatment gap in cancer management.
Methods
A search of the medical literature was performed for research published between January 1990 and December 2015. Case reports and non-English-language articles were excluded, focusing instead on large, population-based studies from national or international datasets. A total of 54 studies were initially identified, 30 of which are included in this review.
Incidence
The incidence of penile cancer varies within specific racial/ethnic and socioeconomic groups, and a summary of the reviewed literature analyzing disparities in penile cancer incidence based on large population-based data sets is shown in Table 1 . [8] [9] [10] Hernandez et al 8 examined the burden of invasive squamous cell carcinoma (SCC) of the penis in the United States from 1998 to 2003 based on data from the Surveillance, Epidemiology, and End Results (SEER) program of the National Cancer Institute. The annual, average age-adjusted incidence rate of penile SCC was 0.81 cases per 100,000 men, and rates steadily increased with age. 8 The incidence of penile SCC was comparable in whites and African Americans, but it was approximately twofold lower in Asians and Pacific Islanders. 8 Rates among Hispanics were 72% higher compared with non-Hispanics, which may be attributable to a decreased prevalence of circumcision in this ethnic group.
11 From 1993 to 2002, white Hispanics had the highest incidence rates of penile cancer (1.01 per 100,000 men) followed by Alaska Natives/American Indians (0.77 per 100,000 men) and African Americans (0.62 per 100,000 men).
11 Incidence of penile SCC was also elevated in the southern United States and in regions of lower socioeconomic status. However, the study had limitations because the education level of participants was not analyzed.
Colón-López et al 10 compared the incidence of penile cancer in Puerto Rico with other racial and ethnic groups in the United States. Puerto Rican men had a higher incidence of penile cancer than non-Hispanic white men (standardized rate ratio [SRR] 3.33), nonHispanic African American men (SRR 3.04), and other US Hispanic men (SRR 2.59). 10 This difference was more pronounced for Puerto Rican men younger than 60 years of age when compared with similarly aged US counterparts. 10 Puerto Rican men with the lowest socioeconomic status had a 70% higher incidence rate of penile cancer than Puerto Rican men with the highest socioeconomic status (SRR 1.70). 10 Less education (< 12 years of education) was also statistically associated with a higher incidence rate of penile cancer among Puerto Rican men (SRR 2.18). 10 However, the overall rate of penile cancer in Puerto Rico declined over time.
In other studies, Hispanic and African American men have been reported to have the highest age-adjusted rates of penile cancer compared with whites, Asians, or American Indians. 9, 12 The highest rates of penile cancer were observed in Hispanic and African American men older than 85 years of age, but penile cancer was rare among males younger than 20 years of age. Analyses to assess temporal trends from 1995 to 2003 revealed a statistically significant decline in the incidence of penile cancer for African Americans and whites. Approximately 60% of penile cancers were diagnosed at a localized stage (≤ pT2) among all racial and ethnic groups, although Hispanic and African American men tended to be diagnosed at an advanced stage (≥ pT3) with a higher incidence of node-positive disease than whites. 9 Racial and ethnic differences in tumor grade were not found. The incidence of penile cancer was highest in the southern United States and lowest in the western states. The highest age-adjusted incidence rate of penile SCC was seen in African American men living in the southern United States, and the lowest rate was found among Asian-Pacific Islanders living in western states. 9 The incidence of primary malignant penile cancer has decreased significantly over time from 1973 to 2002 based on data from SEER; however, the incidence of nodal disease has increased over time. 13 The overall incidence of penile cancer in the United Kingdom (England and Wales) is higher than in Australia and the United States, although the incidence of penile cancer in all 3 countries was stable over time.
14 Although cancer-specific mortality rates were higher in England and Wales compared with Australia and the United States, the incidence ratios were similar for all 3 countries.
14 In Finland, the age-adjusted incidence rate of penile cancer has decreased from the 1960s onward. 15 Penile cancer was primarily a disease of elderly men during this time in Finland, and no systematic geographical variation or predilection in terms of incidence was observed. 15 The most common predisposing risk factors in Finland were phimosis (44% of cases) and condylomatous genital lesions (20% of cases).
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Human Papillomavirus Infection
An estimated 40% to 80% of invasive penile cancers have been linked to HPV infection. [16] [17] [18] Warty and basaloid penile carcinomas have been associated with HPV infection, particularly HPV types 16 and 18, more so than typical SCC or verrucous carcinoma of the penis. 19, 20 No significant association between HPV status and pathological tumor stage, grade, or LN status was found in this study. 19 The impact of HPV infection on the prognosis of patients with penile cancer is still controversial. Lont et al 21 reported an association between high-risk HPV infection and reduced disease-specific mortality from penile cancer (hazard ratio [HR] 0.14), whereas Hernandez et al 16 observed no association between HPV status and rate of survival in patients with penile cancer. HPV-associated penile malignancies, similar to other nonviral penile cancers, have been associated with lower education level (incidence density ratio 1.32; P = .0002) and income status (incidence density ratio 1.59; P < .0001). 22 Current and former smokers were significantly more likely to have an α-HPV infection than any other type. 23 In a study by Chaux et al 3 of 103 Paraguayans with penile cancer, patients with penile cancer were generally found to dwell in rural or suburban areas (82%), live below the poverty line (75%), have a lower level of education (91%), and have a significant smoking history (76%). Phimosis (57%), moderate or poor hygienic habits (90%), and a history of sexually transmitted infections (74%) were also observed. 3 Patients with more than 10 lifetime female sexual partners were nearly 4 times as likely to present with HPV-positive penile tumors when compared with patients who had fewer than 6 lifetime female sexual partners. 3 However, this trend was not significant when the number of sexual partners was adjusted for age at first coitus and past history of sexually transmitted infections. HPV-positive tumors were found in 36% of cases studied, and they were characterized by warty or basaloid morphology in addition to a high histological grade in the majority of cases.
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Treatment
The management of penile carcinoma has evolved in recent years, resulting in a shift in the treatment of the disease. 24 Options for the treatment of localized disease have expanded to organ-sparing therapy, and treatment of advanced disease has developed into a multidisciplinary, team-based approach using multimodal therapies. 24 Demographical, racial/ethnic, and socioeconomic disparities can influence the treatments offered for patients with penile cancer in different populations (Table 2) . 25, 26 Zhu et al 26 used data from SEER to identify individuals diagnosed with penile SCC from 1998 to 2009 and treated with either local tumor excision or partial or total penectomy for their primary tumor. Of the 1,292 eligible patients, 24.2% underwent local tumor excision for surgical treatment of penile cancer. 26 For stage T1 disease, the rates of local tumor excision increased from 29% to 40% within 10 years. 26 Following a multivariable analyses, age younger than 65 years, African American descent, tumor size of less than 3 cm, and pathological stage disease of no higher than T1 were reported predictors for the use of local tumor excision as surgical treatment of the primary penile tumor as part of a penile-sparing approach. 26 The authors concluded that penile-sparing surgery is underutilized in the general population, and significant age and racial/ethnic disparities exist in its use. 26 Other studies have noted that the majority of pa- tients identified with penile SCC in the SEER data set were treated with surgical therapy, and a small percentage of patients received radiotherapy alone or as adjuvant therapy. 27, 28 No statistically significant sociodemographic or racial/ethnic differences were reported with regard to radiotherapy for penile cancer due to small sample size. 28 Zhu et al 25 also assessed the impact of patient characteristics on the extent of inguinal LN dissection when it is clinically indicated for patients with high-risk penile SCC. Using SEER data, the authors identified 393 patients who underwent regional LN dissection for penile cancer; this study cohort was then stratified into 2 groups, limited LN dissection (< 8 LNs removed) and extensive LN dissection (≥ 8 LNs removed). 25 The median number of dissected LNs in this series was 15, and 28% of patients underwent limited LN dissection. 25 The prevalence of extensive LN dissection decreased in tandem with increasing age (81% in men aged < 50 years to 65% in men aged ≥ 70 years). 25 On multivariable analysis, age alone was the independent predictor of extensive LN dissection (odds ratio 0.98; P = .01). 25 Inadequate LN dissection with few LNs removed was observed in some patients with penile cancer, particularly among elderly men, even despite evidence that inguinal lymphadenectomy has a similar morbidity rate in this age group compared with men younger than 65 years of age.
25,26
Survival
Factors affecting health insurance coverage and access to early detection and treatment could influence the cancer-specific mortality rate of penile cancers. A summary of the literature analyzing disparities in penile cancer survival rates based on select, large population-based data sets is shown in Table 3 . 3, 8, 27, [30] [31] [32] Rippentrop et al 27 first described the racial and socioeconomic disparity in survival from penile carcinoma based on data from SEER. They reported that African American men presented at a younger age and with a higher stage of disease compared with other racial groups. The disease-specific risk of death for African American men was also nearly twice as high than for whites (P = .0023), and marriage was associated with improved disease-specific rates of survival in the localized (P = .0002) and regional stages (P = .001) of disease. 27 Multivariable analysis demonstrated that a higher stage at diagnosis, age older than 65 years, African American race, and positive LNs were all significant independent predictors of cancer-specific survival from penile carcinoma. 27 Thuret et al 32 also used SEER data to evaluate the association between marital status, tumor stage and grade, overall mortality, and cancer-specific mortality in patients with penile SCC. Multivariable logistic regression models revealed that unmarried men had a 1.5-fold higher risk of having locally advanced (pT3/T4, N + , M + ) or higher grade (grade 3/4) disease at the time of surgery (P < .001) and a 1.3-fold higher risk of overall mortality (P = .001); however, marital status had no effect on cancer-specific mortality. 32 Age, socioeconomic status (median family income above or below the poverty line within the patient's county of residence), and race (white vs African American vs other) did not correlate with rates of locally advanced or higher-grade disease and cancer-specific mortality. 32 However, the study was limited by its small sample size of African Americans (n = 183).
In a multivariable competing-risk model, Thuret et al 33 studied a population of patients with cN0T1 penile SCC after primary tumor excision and before initial LN dissection and found no statistically significant association between race and age (≥ 70 vs ≤ 69 years) for cancer-specific mortality after accounting for tumor grade. Tyson et al 30 also found no significant association between age and penile SCC-specific mortality rate after adjusting for tumor grade based on SEER data. Penile tumors on the body of the penis (HR 1.61) and overlapping lesions (HR 1.79; P = .01) had increased cancer-specific mortality compared with preputial lesions. 30 Furthermore, the disease-specific 10-year survival rate of those with preputial tumors was 89.4% compared with 78.7% for tumors at other locations combined (P < .0001). 30 Hernandez et al 8 analyzed more than 4,900 cases of histologically confirmed invasive penile SCC in the United States using SEER data, the Centers for Disease Control and Prevention's National Program for Cancer Registries, and the National Center for Health Statistics. The authors found that the rate of mortality due to penile SCC increased with age (mortality rate at age < 50 years: 0.02 vs age > 80 years: 1.80). 8 African American men were also diagnosed at a significantly younger age than white or Asian men (median age, 62 vs 68 vs 68 years, respectively) and had a lower incidence-tomortality ratio than white or Asian men (3.44 vs 5.18 vs 5.63, respectively; P < .01 for all). 8 This was also true for Hispanic men compared with non-Hispanic men (median age, 58 vs 69 years; incidence-to-mortality ratio: 4.61 vs 5.25; P < .01). 8 Rate of mortality due to penile SCC was also increased among those men living in southern states, in regions of lower socioeconomic status, and among those living in areas with lower levels of educated people. 8 Sharma et al 31 used the National Cancer Database (NCDB) to study patients with a diagnosis of penile SCC from 1998 to 2011, and they found that African American and Hispanic men were diagnosed at a younger age (< 55 years: 38.3% vs 25.9% and 51.0% vs 24.5%; P < .01), and African Americans presented with a higher stage of disease (pT3/T4: 16.6% vs 13.2%; P = .027) and had worse median overall survival (OS) rates (68.6 vs 93.7 months; P < .01). The estimated median OS rate in the entire cohort was 91.9 months at a median follow-up period of 44.7 months, and survival did not change over the study period. 31 Hispanic ethnicity was not associated with all-cause mortality in the penile cancer population. 31 Location and education level also did not have a significant relationship with OS. Patients with private health insurance and a median income of at least $63,000 based on zip code presented with a lower stage of disease (pT3/T4: 11.6% vs 14.7%, P = .002; 12.0% vs 14.0%, P = .042) and had better median rates of OS (163.2 vs 70.8 months, P < .01; 105.3 vs 86.4 months, P = .001). 31 Multivariable analysis revealed that African American race (HR 1.39; 95% confidence interval [CI]: 1.21-1.58; P < .01) was independently associated with worse OS, whereas private insurance (HR 0.79; 95% CI: 0.63-0.98; P = .028) and higher median income of at least $63,000 (HR 0.82; 95% CI: 0.72-0.93; P = .001) were independently associated with better OS. 31 Colón-López et al 10 compared the mortality rates of penile cancer in Puerto Rican men with other racial and ethnic groups in the United States and evaluated the influence of socioeconomics and educational level on the rates of mortality observed in Puerto Rico. From 2000 to 2004, Puerto Rican men had a statistically significant higher mortality rate when compared with non-Hispanic white men (HR 3.32), non-Hispanic African American men (HR 2.51), and other US Hispanic men (HR 1.89). 10 A higher rate of mortality related to penile cancer was also observed among Puerto Rican men in the lowest socioeconomic status (HR 1.61) when compared with Puerto Rican men in the highest socioeconomic status, although this difference was not statistically significant. 10 An increasing trend in mortality due to penile cancer was observed among men in Puerto Rico due to a possible convergence of early and high levels of sexual activity, low circumcision rates, and high prevalence rates of sexually transmitted infections in Puerto Rico -particularly among the medically underserved.
Paiva et al 34 reported an increased cancer-specific mortality rate in patients younger than 40 years of age at a mean follow-up period of 22.4 months (19%) compared with patients aged between 40 and 60 years (11%) and those older than 60 years of age (13%; P < .05). Younger patients also had an increased likelihood of perineural invasion (26% vs 13%) and infiltrative growth pattern (70% vs 50%) on pathological review, and they had a higher risk of recurrence (45% vs 25%; P < .05 for all). 34 Study findings from Sharma et al 31 similarly showed an increased prevalence of node-positive disease in patients younger than 55 years of age compared with those older than 75 years (21.5% vs 13.1%; P < .01) but a decreased prevalence of pT3 to T4 disease (12.0% vs 15.4%; P = .007). Others have also shown younger men (< 50 years) were more likely to receive more extensive LN dissection (> 8 LNs removed) than older men (> 70 years; 81% vs 65%; P = .01) with better rates of cancer-specific survival (P = .006). 25 These findings remained true even in the subgroup of study patients with node-positive penile cancer (P = .01). 25 Older age was an independent predictor of OS in the populationbased study using the NCDB on multivariable analysis (P < .01), but its relationship with cancer-specific mortality is unknown. 31 Large population-based data have also been used to demonstrate penile cancer survival trends over time. The NCDB study did not show a correlation between the year of diagnosis and OS during the period from 1998 to 2011. 31 However, Verhoeven et al 35 reported that the 5-year cancer-specific survival rate of patients with penile cancer in the United States has significantly decreased from 72% to 63% based on SEER data, and they also confirmed a significantly increasing relative risk of death with increasing age (relative increase risk of death = 1.15; P < .01). Other groups have also observed an increase in the incidence of regional-stage disease (pN + ) over time in US men that also paralleled rising age. 36 Furthermore, Arya et al 37 reported on more than 9,500 men diagnosed with pri-mary penile cancer in England from 1979 to 2009 and noted that the mortality rates fell by 20% after 1994 (from 0.39 to 0.31 per 100,000 men). The 5-year survival rate they observed also increased from 61.4% to 70.2%, and the 5-year survival rate for men diagnosed between 2006 and 2010 was 77% for men younger than 60 years of age and 53% for men older than 80 years of age. 37 The 8% difference in 5-year survival rate (66% vs 74%) between men living in the most affluent vs the most deprived areas during this time was not statistically significant. 37 The authors propose that the 21% increase in incidence of penile cancer since the 1970s in England could be explained by changes in sexual habits, greater exposure to sexually transmitted infections, such as HPV infection, and the decreasing rates of childhood and neonatal circumcision. 37 They also suggest that the improvement in survival may be due to advances in medical care, including diagnostic, staging, and surgical techniques.
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Conclusions
Disparities exist in the incidence, treatment, and outcomes of penile carcinoma. Younger patients are often offered more penile-sparing approaches for primary tumors but more aggressive treatment such as lymphadenectomy for nodal disease. African American men, Hispanics, the uninsured, those who are less educated, and those with lower socioeconomic status appear to have lower rates of survival when compared with their insured, educated, white, non-Hispanic counterparts. Marital status, number of sexual partners, and human papillomavirus status also seem to play a role in prognosis. Although the treatment options and rates of survival from penile squamous cell carcinoma have improved during the past several decades, further understanding of the racial/ethnic, socioeconomic, and age-related differences seen in penile malignancies may help minimize future disparities in cancer care.
